2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1043476625 M.D.
Verify on CMS →

Lalitha Subramanyam, M.D.

Endocrinology, Diabetes & Metabolism Physician in Irving, Texas.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 344 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
43%
generic claims · 50% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

Lalitha Subramanyam, M.D. filed 3,111 Medicare Part D claims in 2023 as an Endocrinology, Diabetes & Metabolism Physician in Irving, Texas, prescribing 43% generic.

3K
Part D claims, 2023
43%
generic prescribing
≥89th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Lalitha Subramanyam, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

3,111 ≥ 89th percentile 89% of 1,370,886 prescribers are in lower value bands

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2K+: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic, not verified)

Lalitha Subramanyam, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Lalitha Subramanyam, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/02/2008

NPI 1043476625

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,871 US NPIs in this specialty

Medicare Part D claims

3,111 18% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Texas

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Texas providers

Texas providers
Behavior Technician5.6%Student in an Organized Heal…5.1%Family Nurse Practitioner4.5%Professional Counselor4.4%Pharmacist4.4%Speech-Language Pathologist3.9%Endocrinology, Diabetes & Me…0.1%
Largest specialties in Texas (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Lalitha Subramanyam, M.D. appears in the CMS NPPES registry as an Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 2021 N MACARTHUR BLVD, Irving, TX, 75061, with a listed phone of (972) 259-3282. NPI 1043476625 was issued on 08/02/2008.

Medicare Part D records for calendar year 2023 show 3,111 prescription claims written by this provider, covering 344 Medicare beneficiaries and totaling roughly $1.8 million in drug spend, split 50% brand-name and 43% generic by claim count.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2021 N MACARTHUR BLVD
Irving, TX 75061

Provider Details

NPI 1043476625
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Female
NPI Issued 08/02/2008

License & disciplinary context - Texas TMB 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Lalitha Subramanyam, M.D.. To verify Lalitha Subramanyam, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

Lalitha Subramanyam, M.D. - brand share 50.0%
Endocrinology, Diabetes & Metabolism Physician average

50% brand-name claims vs 43% generic, on 3,111 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

3,111
Total Claims
$1.8M
Total Drug Cost
344
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
7,243
Total Day Supply
215,052
Brand vs Generic
50% brand / 43% generic
Brand Drug Cost
$1.7M
Generic Drug Cost
$29K

Patient Demographics

Average Patient Age
71.7 years
Avg HCC Risk Score
1.56
Gender Split
64% female / 36% male
Age Distribution
<65: 33, 65-74: 197, 75-84: 98, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Lalitha Subramanyam, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
308
Ozempic
Semaglutide
205
Metformin Hcl Er
Metformin Hcl
179
Trulicity
Dulaglutide
123
Metformin Hcl
101
Humalog Kwikpen U-100
Insulin Lispro
78
Novolog Flexpen
Insulin Aspart
74
Glimepiride
71
Jardiance
Empagliflozin
71
Rosuvastatin Calcium
70

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How Lalitha Subramanyam, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

Lalitha Subramanyam, M.D.'s 3,111 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Subramanyam.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Texas medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Lalitha Subramanyam, M.D.'s specialty?
Lalitha Subramanyam, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Irving, Texas. Credentials: M.D..
How much does Lalitha Subramanyam, M.D. prescribe under Medicare Part D?
In 2023, Lalitha Subramanyam, M.D. wrote 3,111 Medicare Part D claims totaling $1.8M in drug costs for 344 beneficiaries.
Where is Lalitha Subramanyam, M.D. located?
Lalitha Subramanyam, M.D. is located at 2021 N MACARTHUR BLVD, Irving, TX, 75061. Phone: (972) 259-3282.
What is Lalitha Subramanyam, M.D.'s NPI number?
Lalitha Subramanyam, M.D.'s National Provider Identifier (NPI) is 1043476625, issued on 08/02/2008.
Does Lalitha Subramanyam, M.D. prescribe more brand-name or generic drugs?
Lalitha Subramanyam, M.D.'s prescribing is 50% brand-name and 43% generic drugs by claim count, with $1.7M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Lalitha Subramanyam, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Lalitha Subramanyam, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Metformin Hcl Er. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lalitha Subramanyam, M.D. accept Medicare?
Lalitha Subramanyam, M.D. appears in CMS Medicare data with 3,111 Part D claims and 344 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lalitha Subramanyam, M.D.'s credentials?
Lalitha Subramanyam, M.D.'s NPI is 1043476625 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.